Sign Up

Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand

HONG KONG, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported a profitable first half of 2025, supported by an expanding user base, higher operating efficiency, and accelerated deployment of AI across its healthcare services and internal operations.

Net Profit Swings to Positive as Targeted User Base Unlocks Growth Fangzhou posted revenue of RMB 1.494 billion for the six months ended June 30, up 12.9% from a year earlier. Net profit reached RMB 12.5 million, compared with a loss of RMB 818.7 million in the same period last year. Adjusted net profit also increased 16.8% to RMB 17.6 million, marking a new high.

Registered users on the platform grew 15.8% year-on-year to 52.8 million, while monthly active users surged 34.4% to 11.9 million. Registered doctors increased to 229,000. Paid user repurchase rate rose to 85.4%, underscoring high user stickiness.

Revenue from online retail pharmacy services climbed 28.2% to RMB 864 million, while medical services revenue rose 11.4% to RMB 357 million. By mid-2025, the company's drug catalog reached 215,000 SKUs, with prescription medicines accounting for about ...